Flow Cytometric Bone Marrow Evaluation in Suspected Myelodysplastic Neoplasms

Area of Science:

• Hematology
• Oncology
• Immunophenotyping

Background:

• Myelodysplastic neoplasms (MDS) are clonal stem cell disorders characterized by ineffective hematopoiesis and a risk of transformation to acute myeloid leukemia.
• MDS are associated with an inflammatory microenvironment and genomic instability, affecting multiple cell lineages and causing cytopenias.
• Multi-parameter flow cytometry detects aberrant antigen expression, correlating with dysplasia and aiding in MDS diagnosis and prognosis.

Purpose of the Study:

• To detail the utility of flow cytometry in evaluating bone marrow for suspected myelodysplastic neoplasms.
• To highlight characteristic flow cytometry findings in MDS, including aberrant maturation and marker expression.
• To emphasize flow cytometry's role in differentiating MDS from other cytopenic conditions.

Main Methods:

• Utilizing multi-parameter flow cytometry to analyze bone marrow samples.
• Employing a recommended set of markers and technical guidelines from the European LeukemiaNet.
• Identifying at least three distinct aberrations in at least two cell lineages as indicative of MDS.

Main Results:

• Flow cytometry detects aberrant antigen expression patterns characteristic of MDS, correlating with cytomorphological dysplasia.
• Key findings include increased myeloid progenitor cells, aberrant maturation, and abnormal marker expression (lineage infidelity, asynchronous expression).
• Flow cytometry can effectively rule out other causes of cytopenia, such as lymphomas or acute leukemias.

Conclusions:

• Flow cytometry is a valuable tool for the diagnosis and prognosis of myelodysplastic neoplasms.
• The presence of specific aberrant immunophenotypic findings strongly suggests MDS.
• This method provides essential diagnostic information and aids in differential diagnosis of cytopenias.